drugset / Trial / NCT00112034
AVONEX® Combination Trial - "ACT"
RandomizedFactorialDouble-blind
Summary
The purpose of this study is to determine the efficacy and safety of combination therapy with AVONEX plus low dose oral methotrexate (MTX), every other month courses of intravenous methylprednisolone (IVMP), or both in patients with continued disease activity on AVONEX monotherapy.
Timeline
- Start
- 2003-06
- Primary completion
- 2006-06
- Completion
- 2007-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Methotrexate | Small molecule | — | Oral |
| Subject | Methylprednisolone | Other / unclassified | — | Intravenous |